| 524 |
Gluten-driven immune activation leading to celiac disease in genetically predisposed individuals |
Antonio Fernandez Dumont |
BY-SA |
3 MIEs
|
2257: Celiac disease
|
Under Review |
1.98 |
| 523 |
Retinoic acid receptor agonism during neurodevelopment leading to microcephaly |
Diana Lupu |
Open for adoption |
2201: Agonism, Retinoic acid receptor
|
1978: Increase risk, microcephaly
|
|
|
| 522 |
Estrogen antagonism leading to increased risk of autism-like behavior |
Kanglong Cui |
Open for adoption |
112: Antagonism, Estrogen receptor
|
2209: autism-like behavior
|
|
|
| 521 |
Essential element imbalance leads to reproductive failure via oxidative stress |
Travis Karschnik |
BY-SA |
2205: Increased, essential element imbalance
|
2147: Decreased, Viable Offspring
|
|
|
| 520 |
Retinoic acid receptor agonism during neurodevelopment leading to impaired learning and memory |
Diana Lupu |
Open for adoption |
2201: Agonism, Retinoic acid receptor
|
341: Impairment, Learning and memory
|
|
|
| 519 |
Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality |
Young Jun Kim |
Open for adoption |
2282: Cardiac ion channels blockade
|
1929: Increased incidence of cardiovascular morbidity and mortality in the general population
|
|
|
| 518 |
Liver X Receptor (LXR) activation leads to liver steatosis |
John Frisch |
BY-SA |
167: Activation, LXR
|
459: Increase, Liver steatosis
|
|
|
| 517 |
Pregnane X Receptor (PXR) activation leads to liver steatosis |
John Frisch |
BY-SA |
239: Activation, Pregnane-X receptor, NR1I2
|
459: Increase, Liver steatosis
|
|
|
| 516 |
Na+ /K+ -ATPase inhibition leading to hypertension |
Michelle Angrish |
BY-SA |
1562: Decreased Na/K ATPase activity
|
952: Hypertension
|
|
|
| 515 |
An overview of adverse outcome pathway linked between PM2.5 exposure and congenital heart defects |
Liang Chen |
BY-SA |
None
|
None
|
|
|
| 514 |
PLK1 Activation leading to hepatocyte apoptosis-associate liver injury via autophagy-mediated excessive COX6A1 degradation and impaired function of mitochondrial respiratory chain complex IV |
Hui Li |
BY-SA |
None
|
None
|
|
|
| 513 |
Reactive Oxygen (ROS) formation leads to cancer via Peroxisome proliferation-activated receptor (PPAR) pathway |
John Frisch |
BY-SA |
1115: Increase, Reactive oxygen species
|
885: Increase, Cancer
|
|
|
| 512 |
Reduced availability of GnRH leading to uterine adenocarcinoma via increased estrogen availability at target organ level |
Ana-Andreea Cioca |
BY-SA |
None
|
None
|
|
|
| 511 |
The AOP framework on ROS-mediated oxidative stress induced vascular disrupting effects |
Yanhong Wei |
BY-SA |
1115: Increase, Reactive oxygen species
|
2161: Increase, Vascular disrupting effects
|
|
|
| 510 |
Demethylation of PPAR promotor leading to vascular disrupting effects |
Yanhong Wei |
BY-SA |
228: peroxisome proliferator activated receptor promoter demethylation
|
2161: Increase, Vascular disrupting effects
|
|
|
| 509 |
Nrf2 inhibition leading to vascular disrupting effects through activating apoptosis signal pathway and mitochondrial dysfunction |
Yanhong Wei |
BY-SA |
1417: NFE2/Nrf2 repression
|
2161: Increase, Vascular disrupting effects
|
|
|
| 508 |
Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway |
Yanhong Wei |
BY-SA |
1417: NFE2/Nrf2 repression
|
2161: Increase, Vascular disrupting effects
|
|
|
| 507 |
Nrf2 inhibition leading to vascular disrupting effects via inflammation pathway |
Yanhong Wei |
BY-SA |
1417: NFE2/Nrf2 repression
|
2161: Increase, Vascular disrupting effects
|
|
|
| 506 |
Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation |
Jessica Resnick |
All rights reserved |
2158: Influenza A Virus (IAV) binds sialic acid glycan receptor
|
2194: Influenza A Virus (IAV) shedding and transmission
|
|
|
| 505 |
Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway |
John Frisch |
BY-SA |
1115: Increase, Reactive oxygen species
|
885: Increase, Cancer
|
|
|
| 504 |
SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level |
Martina Panzarea |
BY-SA |
2155: Inhibition of Sulfotransferase E1 (SULT1E1)
|
1065: Activation, estrogen receptor alpha
|
|
|
| 503 |
Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation |
Barbara Viviani |
BY-SA |
1065: Activation, estrogen receptor alpha
|
2154: Uterine adenocarcinoma (endometrioid adenocarcinoma Type I)
|
Under Review |
1.100 |
| 502 |
Decrease, cholesterol synthesis leads to orofacial clefting |
Jacob Reynolds |
BY-SA |
None
|
2042: Increase, Orofacial clefting
|
Under Development |
1.101 |
| 501 |
Excessive iron accumulation leading to neurological disorders |
Young Jun Kim |
Open for adoption |
2149: Increased intracelluar Iron accumulation
|
2150: Neurological disorder
|
|
|
| 500 |
Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis |
Travis Karschnik |
BY-SA |
2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2
|
341: Impairment, Learning and memory
|
|
|